Skip to main content

Chlamydia Trachomatis Infection

0
Pipeline Programs
5
Companies
4
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

5 companies ranked by most advanced pipeline stage

Human BioSciences
Human BioSciencesWV - Martinsburg
1 program
Ct/GC screeningN/A1 trial
Active Trials
NCT03098329Completed1,907Est. May 2021
Abbott
AbbottABBOTT PARK, IL
1 program
ID NOW™N/A1 trial
Active Trials
NCT06395675Unknown7,100Est. Jan 2025
Roche
RocheSTAVANGER NORWAY, Norway
1 program
cobas® liat CT/NG/MG nucleic acid testN/A
Genentech
GenentechCA - Oceanside
1 program
cobas® liat CT/NG/MG nucleic acid testN/A1 trial
Active Trials
NCT06369220Completed344Est. May 2025
Evofem Biosciences
Evofem BiosciencesCA - San Diego
1 program
EVO100PHASE_2_31 trial
Active Trials
NCT03107377Completed860Est. Aug 2019

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Evofem BiosciencesEVO100
Genentechcobas® liat CT/NG/MG nucleic acid test
AbbottID NOW™
Human BioSciencesCt/GC screening

Clinical Trials (4)

Total enrollment: 10,211 patients across 4 trials

NCT03107377Evofem BiosciencesEVO100

Phase 2B/3 Double-blinded Placebo-controlled

Start: Nov 2017Est. completion: Aug 2019860 patients
Phase 2/3Completed
NCT06369220Genentechcobas® liat CT/NG/MG nucleic acid test

A Study of the Cobas® Liat CT/NG/MG Test Versus Current Standard Practice for Managing Participants at Increased Risk of Sexually Transmitted Infections

Start: Jul 2024Est. completion: May 2025344 patients
N/ACompleted
NCT06395675AbbottID NOW™

Clinical Evaluation of the ID NOW™ CT/NG Test

Start: Jul 2024Est. completion: Jan 20257,100 patients
N/AUnknown
NCT03098329Human BioSciencesCt/GC screening

Check it: A New Approach to Controlling Chlamydia Transmission in Young People

Start: May 2017Est. completion: May 20211,907 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

5 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.